Therapeutic Digest

Digital Therapeutics

September 15, 2020

The convergence of the conventional pharmaceutical industry with modern digital technologies is expected to open up a whole new set of opportunities. Digital healthcare technologies can help reduce healthcare costs and improve treatment outcomes, especially for lifestyle and chronic diseases. Investments in DTx companies in the United States have grown by an average of 40% a year over the past seven years to reach more than $1 billion in 2018. Investors’ enthusiasm mirrors the growing demand for DTx products and tools across the healthcare ecosystem.

Post a Comment

You must be logged in to post a Comment.